A Subject Expert Committee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from A subject expert committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In A Subject Expert Committee Today - Breaking & Trending Today

New-Gen COVID Jabs Coming Soon...

India currently does not have any XBB 1.5 variant-based vaccines available. ....

Jayaprakash Muliyil , Shahid Jameel , Novavax Covid , Technical Advisory Group , European Union , Serum Institute , Expert Committee , World Health Organisation , Green Templeton College , A Subject Expert Committee , Serum Institute Of India , University Of Oxford , Subject Expert Committee , Pune Based Serum Institute , Advisory Group , Business Standard ,

Covishield, Covaxin likely to be capped at Rs 275 after approval

The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India’s drug regulator, is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150, official sources said.According to them, the National Pharmaceutical Pricing Authority (NPPA) has been directed to […] ....

V Krishna Mohan , Prakash Kumar Singh , National Pharmaceutical Pricing Authority , Central Drugs Standard Control Organisation On , A Subject Expert Committee , Subject Expert Committee , Central Drugs Standard Control Organisation , Kumar Singh , Serum Institue , Drugs Controller General , Bharat Biotech , Emergency Use Authorisation ,

Covishield, Covaxin likely to be capped at Rs 275 after regular market approval

The price is likely to be capped at Rs 275 per dose along with an additional service charge of Rs 150. ....

New Delhi , V Krishna Mohan , Prakash Kumar Singh , National Pharmaceutical Pricing Authority , Central Drugs Standard Control Organisation On , A Subject Expert Committee , Subject Expert Committee , Central Drugs Standard Control Organisation , Kumar Singh , Serum Institue , Drugs Controller General , Bharat Biotech , Emergency Use Authorisation , Covid 19 , Covid 19 Vaccine , Ovaxin Market Price , Covishield Vaccine Price , Ovid Vaccine Market Price ,

Covisheild, Covaxin price likely to be capped at Rs 275 per dose after DCGI approval

Covisheild, Covaxin price likely to be capped at Rs 275 per dose after DCGI approval - The price of Covisheild and Covaxin will most likely be capped at Rs 275 per dose after getting market approval from DCGI. ....

V Krishna Mohan , Prakash Kumar Singh , National Pharmaceutical Pricing Authority , Central Drugs Standard Control Organisation On , A Subject Expert Committee , Subject Expert Committee , Central Drugs Standard Control Organisation , Kumar Singh , Serum Institue , Drugs Controller General , Bharat Biotech , Emergency Use Authorisation , Covid 19 Vaccine , Covaxin Price , Ovisheild Price , Covid 19 Vaccine In India , Ovid 19 News , Serum Institute Of India , Bharat Biotech , Emergency Use Authorisation ,

Covishield, Covaxin dose to be capped at Rs 275 after getting market approval

The National Pharmaceutical Pricing Authority has been directed to start working towards capping the price to make the vaccines affordable, sources said. ....

V Krishna Mohan , Prakash Kumar Singh , National Pharmaceutical Pricing Authority , Central Drugs Standard Control Organisation On , A Subject Expert Committee , Subject Expert Committee , Central Drugs Standard Control Organisation , Kumar Singh , Serum Institue , Drugs Controller General , Bharat Biotech , Emergency Use Authorisation ,